Drug Facts
Composition & Profile
Identifiers & Packaging
HOW SUPPLIED Texacort Topical Solution 2.5% is available in a 1 fl. oz. plastic bottle with an applicator tip, NDC 0178-0455-01, and in a 3 mL sample packet, NDC 0178-0455-03. Store at controlled room temperature 15° to 30°C (59° to 86°F).; PRINCIPAL DISPLAY PANEL - 30 mL Bottle, with Applicator Carton NDC 0178-0455-01 Texacort™ Topical Solution 2.5% HYDROCORTISONE TOPICAL SOLUTION Paraben and Lipid-Free Contains hydrocortisone 2.5% (W/V) In a vehicle of alcohol (48.8% W/W), purified water, polysorbate 20 and isoceteth-20. Rx ONLY 1 fl. oz. (30 mL) PRINCIPAL DISPLAY PANEL - 30 mL Bottle, with Applicator Carton
- HOW SUPPLIED Texacort Topical Solution 2.5% is available in a 1 fl. oz. plastic bottle with an applicator tip, NDC 0178-0455-01, and in a 3 mL sample packet, NDC 0178-0455-03. Store at controlled room temperature 15° to 30°C (59° to 86°F).
- PRINCIPAL DISPLAY PANEL - 30 mL Bottle, with Applicator Carton NDC 0178-0455-01 Texacort™ Topical Solution 2.5% HYDROCORTISONE TOPICAL SOLUTION Paraben and Lipid-Free Contains hydrocortisone 2.5% (W/V) In a vehicle of alcohol (48.8% W/W), purified water, polysorbate 20 and isoceteth-20. Rx ONLY 1 fl. oz. (30 mL) PRINCIPAL DISPLAY PANEL - 30 mL Bottle, with Applicator Carton
Overview
Topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. Texacort Topical Solution contains hydrocortisone as the active corticosteroid, having the chemical formula of Pregn-4-ene-3, 20-dione, 11,17,21-trihydroxy-, (11 β)-. The molecular weight is 362.47. Its empirical formula is C 21 H 30 O 5 and the structural formula is: Each milliliter contains 25 mg of hydrocortisone (2.5% W/V) in a specially formulated vehicle containing alcohol (48.8% W/W), purified water, polysorbate 20 and isoceteth-20. Chemical Structure
Indications & Usage
Texacort Topical Solution 2.5% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroids-responsive dermatoses.
Dosage & Administration
Topical corticosteroids are generally applied to the affected area as a thin film for three or four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
Warnings & Precautions
No warnings available yet.
Contraindications
Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Adverse Reactions
The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, miliaria.
Storage & Handling
Store at controlled room temperature 15° to 30°C (59° to 86°F).
Similar Drugs
Related medications based on brand, generic name, substance, active ingredients.